FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
National Institutes of Health Clinical Center (CC)
AvenCell Therapeutics, Inc.
Allogene Therapeutics
Ossium Health, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Essen Biotech
Center for International Blood and Marrow Transplant Research
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Arizona
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
City of Hope Medical Center
Stanford University
Affiliated Hospital to Academy of Military Medical Sciences
Affiliated Hospital of Nantong University
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Celgene
City of Hope Medical Center
Columbia University
Fate Therapeutics
Fate Therapeutics
University of Nebraska
Alliance for Clinical Trials in Oncology
Bristol-Myers Squibb
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
Medical College of Wisconsin
St. Jude Children's Research Hospital
University of Alabama at Birmingham
St. Jude Children's Research Hospital
The Affiliated People's Hospital of Ningbo University
Loyola University
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
Roswell Park Cancer Institute
Universität des Saarlandes
Icahn School of Medicine at Mount Sinai
Universität des Saarlandes